Access

Research

Nature Biotechnology 21, 414–421 (1 April 2003) | doi:10.1038/nbt799

Enhancement of therapeutic protein in vivo activities through glycoengineering

Steve Elliott , Tony Lorenzini , Sheilah Asher , Ken Aoki , David Brankow , Lynette Buck , Leigh Busse , David Chang , Janis Fuller , James Grant , Natasha Hernday , Martha Hokum , Sylvia Hu , Andrew Knudten , Nancy Levin , Renee Komorowski , Frank Martin , Rachell Navarro , Timothy Osslund , Gary Rogers , Norma Rogers , Geri Trail & Joan Egrie